Best Value Stocks to Buy for January 2nd

Zacks highlights three Zacks Rank #1 (Strong Buy) stocks: Loma Negra (LOMA), Pilgrim's Pride (PPC) and Camden National (CAC). Zacks cites rising consensus earnings estimates over the past 60 days — LOMA +66.7%, PPC +4.3% and CAC +1.2% — and attractive valuations versus the S&P 500 (P/Es of 9.59, 8.87 and 12.25, respectively, vs 24.51), with Pilgrim's Pride carrying a Value Score of A and the others B; the call reflects model-driven analyst estimate revisions rather than material corporate developments.

Analysis

Market structure: LOMA (P/E ~9.6) benefits if Argentine construction and public works accelerate; PPC (P/E ~8.9) wins from stable protein demand and pricing power versus integrated peers; CAC benefits from regional deposit flight-to-quality if rates stay elevated. Commodity and input linkages matter: PPC margins are highly sensitive to corn/soy feed costs (feed ~60% of poultry COGS), while LOMA is cyclical with construction steel/cement demand; ADR/sovereign FX moves will dominate LOMA returns.

Risk assessment: Tail risks include a >20% ARS devaluation or sudden export tax for Argentina that could cut LOMA ADR value 40–60%, an avian-flu outbreak or +25% corn spike that could hit PPC EBITDA by 15–30%, and a rapid Fed easing that could compress CAC NIMs by 10–30 bps. Immediate (days) volatility will follow macro prints; short-term (3–6 months) earnings revisions and input-cost trajectories will drive direction; long-term (12–24 months) outcomes hinge on structural policy and secular demand for housing/meat.

Trade implications: Favor small, hedged long exposures: tactical long PPC on dips with options protection, cautious long LOMA only with explicit FX hedges or collars, and selective overweight in CAC if loan growth >2% QoQ and deposit beta remains low. Use pair trades (PPC vs TSN) to isolate protein margin vs execution, and use 3–9 month option structures to express views while capping downside.

Contrarian angles: Consensus praises low P/Es but underweights macro/policy risk (LOMA) and biological input shock (PPC); LOMA ADR upside may be overstated absent FX stability — historical Argentine ADR rebounds were often reversed by policy shifts. Mispricings exist if you can hedge ARS risk cheaply; otherwise valuations understate tail volatility.

Key Decisions for Investors

• Establish a 1.0–1.5% portfolio long position in PPC with a 6–12 month horizon; initiate on pullback ≥10% from today’s level or if next-quarter consensus EPS rises another ≥5%. Hedge with a 3-month put 7–10% OTM to cap downside; set a hard stop-loss at −20%.
• Initiate a tactical 0.5–1.0% long in LOMA ADR only if paired with FX/sovereign protection: buy LOMA and simultaneously buy a 3–6 month 25% OTM put on the ADR or hedge via Argentina USD sovereign CDS exposure; add only after a ≥10% ADR drawdown or continued +50% EPS revision trend, and cut at ARS move >−20% in 30 days or ADR down −30%.
• Overweight CAC at 1.0–2.0% (relative overweight vs benchmark) with 9–12 month view if quarter-over-quarter loan growth >2% and NIM compression ≤20 bps; if Fed signals two+ rate cuts in next 6 months, trim to neutral. Use covered calls (6–9 month) to generate yield if holding.
• Enter a dollar-neutral pair trade long PPC / short TSN equal notional for 6–12 months to capture relative protein margin improvement; rebalance or exit if spread widens/narrows by >15% or if corn futures change ±20%.